$3.54
At close: Jun 17 EDT
$3.50
-0.04-1.13%
Pre-Market: 7:12 AM EDT
Comments
Loading...
Bionano Genomics Analyst Ratings and Price Targets | NASDAQ:BNGO | Benzinga
Bionano Genomics Inc has a consensus price target of $6.55 based on the ratings of 7 analysts. The high is $10 issued by HC Wainwright & Co. on April 9, 2025. The low is $1.75 issued by EF Hutton on May 25, 2023. The 3 most-recent analyst ratings were released by Maxim Group, HC Wainwright & Co., and Scotiabank on May 20, 2025, April 9, 2025, and April 2, 2025, respectively. With an average price target of $7.33 between Maxim Group, HC Wainwright & Co., and Scotiabank, there's an implied 109.52% upside for Bionano Genomics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Maxim Group
HC Wainwright & Co.
Scotiabank
EF Hutton
Oppenheimer
1calculated from analyst ratings
Analyst Ratings for Bionano Genomics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/20/2025 | Buy Now | 128.57% | Maxim Group | Jason McCarthy42% | → $8 | Upgrade | Hold → Buy | Get Alert |
| 04/09/2025 | Buy Now | 185.71% | HC Wainwright & Co. | Yi Chen61% | → $10 | Initiates | → Buy | Get Alert |
| 04/02/2025 | Buy Now | 14.29% | Scotiabank | Sung Ji Nam46% | $1 → $4 | Maintains | Sector Perform | Get Alert |
| 11/15/2024 | Buy Now | — | Ladenburg Thalmann | Jeff Cohen58% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/10/2024 | Buy Now | — | BTIG | Mark Massaro71% | — | Downgrade | Buy → Neutral | Get Alert |
| 08/28/2024 | Buy Now | -71.43% | Scotiabank | Sung Ji Nam46% | $6 → $1 | Downgrade | Sector Outperform → Sector Perform | Get Alert |
| 05/16/2024 | Buy Now | -42.86% | BTIG | Mark Massaro71% | $3 → $2 | Maintains | Buy | Get Alert |
| 03/07/2024 | Buy Now | 71.43% | Scotiabank | Sung Ji Nam46% | $7 → $6 | Maintains | Sector Outperform | Get Alert |
| 11/13/2023 | Buy Now | — | Maxim Group | Jason McCarthy42% | — | Downgrade | Buy → Hold | Get Alert |
| 08/10/2023 | Buy Now | 185.71% | BTIG | Mark Massaro71% | $2 → $10 | Maintains | Buy | Get Alert |
| 05/25/2023 | Buy Now | -50% | EF Hutton | — | → $1.75 | Initiates | → Buy | Get Alert |
| 05/18/2023 | Buy Now | -42.86% | BTIG | Mark Massaro71% | $3 → $2 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | -14.29% | BTIG | Mark Massaro71% | $3 → $3 | Maintains | Buy | Get Alert |
| 03/10/2023 | Buy Now | -14.29% | BTIG | Mark Massaro71% | → $3 | Maintains | Buy | Get Alert |
| 02/06/2023 | Buy Now | 157.14% | Oppenheimer | Francois Brisebois40% | $12 → $9 | Maintains | Outperform | Get Alert |
| 02/05/2023 | Buy Now | — | BTIG | Mark Massaro71% | $3.5 → $3.5 | Maintains | Buy | Get Alert |
| 01/05/2023 | Buy Now | 14.29% | Scotiabank | Sung Ji Nam46% | → $4 | Initiates | → Sector Outperform | Get Alert |
| 12/12/2022 | Buy Now | — | BTIG | Mark Massaro71% | → $3.5 | Assumes | → Buy | Get Alert |
| 07/18/2022 | Buy Now | 242.86% | Oppenheimer | Francois Brisebois40% | → $12 | Assumes | → Outperform | Get Alert |
FAQ
What is the target price for Bionano Genomics (BNGO) stock?
The latest price target for Bionano Genomics (NASDAQ:BNGO) was reported by Maxim Group on May 20, 2025. The analyst firm set a price target for $8.00 expecting BNGO to rise to within 12 months (a possible 128.57% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bionano Genomics (BNGO)?
The latest analyst rating for Bionano Genomics (NASDAQ:BNGO) was provided by Maxim Group, and Bionano Genomics upgraded their buy rating.
When was the last upgrade for Bionano Genomics (BNGO)?
The last upgrade for Bionano Genomics Inc happened on May 20, 2025 when Maxim Group raised their price target to $8. Maxim Group previously had a hold for Bionano Genomics Inc.
When was the last downgrade for Bionano Genomics (BNGO)?
The last downgrade for Bionano Genomics Inc happened on November 15, 2024 when Ladenburg Thalmann changed their price target from N/A to N/A for Bionano Genomics Inc.
When is the next analyst rating going to be posted or updated for Bionano Genomics (BNGO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bionano Genomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bionano Genomics was filed on May 20, 2025 so you should expect the next rating to be made available sometime around May 20, 2026.
Is the Analyst Rating Bionano Genomics (BNGO) correct?
While ratings are subjective and will change, the latest Bionano Genomics (BNGO) rating was a upgraded with a price target of $0.00 to $8.00. The current price Bionano Genomics (BNGO) is trading at is $3.50, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
